Search

Your search keyword '"van Eijk, Kristel R."' showing total 236 results

Search Constraints

Start Over You searched for: Author "van Eijk, Kristel R." Remove constraint Author: "van Eijk, Kristel R."
236 results on '"van Eijk, Kristel R."'

Search Results

1. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes

2. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

3. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

5. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors

6. Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls

7. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

8. Associations of autozygosity with a broad range of human phenotypes.

9. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

10. Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

11. Genetic variants associated with longitudinal changes in brain structure across the lifespan

12. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

13. Genome‐wide association meta‐analysis of age at first cannabis use

14. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

16. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

17. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

19. Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood

20. Common genetic variants influence human subcortical brain structures

21. Genetic architecture of subcortical brain structures in 38,851 individuals

22. Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study

23. Characterization of genome-methylome interactions in 22 nuclear pedigrees.

24. Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis

25. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

27. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

28. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

30. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects

31. The role of rare compound heterozygous events in autism spectrum disorder

32. Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls

33. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis

34. Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data

36. Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general population

37. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphism

38. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

39. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

40. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors

41. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

43. Phenome-wide and genome-wide analyses of quality of life in schizophrenia

44. Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy

45. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

46. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

47. Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia

48. Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies

49. Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology

50. Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?

Catalog

Books, media, physical & digital resources